Cargando…
Long-Term Effectiveness of Liraglutide in Association with Patients’ Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study
INTRODUCTION: Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are recommended therapy for type 2 diabetes (T2DM) and liraglutide is the most used worldwide. We assessed the glycemic efficacy and extra-glycemic effects of liraglutide during 36 months’ follow-up of individuals with poorly regu...
Autores principales: | Berkovic, Maja Cigrovski, Bilic-Curcic, Ines, Herman Mahecic, Davorka, Gradiser, Marina, Grgurevic, Mladen, Bozek, Tomislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688989/ https://www.ncbi.nlm.nih.gov/pubmed/29076038 http://dx.doi.org/10.1007/s13300-017-0324-x |
Ejemplares similares
-
Are We Compensating for the Lack of Physical Activity in Our Diabetic Patients with Treatment Intensification?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2017) -
Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020) -
The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
por: Božek, Tomislav, et al.
Publicado: (2018) -
The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study
por: Gradiser, Marina, et al.
Publicado: (2015) -
Flash Glucose Monitoring in Croatia: The Optimal Number of Scans per Day to Achieve Good Glycemic Control in Type 1 Diabetes
por: Canecki-Varzic, Silvija, et al.
Publicado: (2023)